New Economic Modeling Shows Improved Lyme Disease Diagnostics Could Cut U.S. Lyme Healthcare Costs by 41.5%
Data to be presented at ADLM 2026 show that adopting a higher-sensitivity diagnostic test could reduce misdiagnosis-related costs by nearly 80%. PHOENIX, July 23, 2026 /PRNewswire/ -- Aces Diagnostics (acesdiagnostics.com) announced findings from an independent health economics analysis...
View original →